Evidence map›Paper›PMID 26597682›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2016

Pediatric thalamic tumors in the MRI era: a Canadian perspective.

Paul Steinbok, Chittur Viswanathan Gopalakrishnan, Alexander R Hengel, Aleksander M Vitali, Ken Poskitt, Cynthia Hawkins, James Drake, Maria Lamberti-Pasculli, Olufemi Ajani, Walter Hader and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Clinical, molecular, and surgical predictors of outcome in non-DIPG pediatric diffuse midline gliomas: A collaborative retrospective analysis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Surgical Approach to Thalamic Tumors.Advances and technical standards in neurosurgery · 2022
    Article
  17. Evolution of surgical attitudes to paediatric thalamic tumours: the alder hey experience.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Review
  18. Article
  19. MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Review
  20. Thalamic tumors in children: case series from our institution and literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 1 country.

Paul SteinbokDivision of Pediatric Neurosurgery, Department of Surgery, University of British Columbia & British Columbia Children's Hospital, 4480 Oak St., Room K3-159, V6H 3V4, Vancouver, BC, Canada. psteinbok@cw.bc.ca.
Chittur Viswanathan GopalakrishnanDivision of Pediatric Neurosurgery, Department of Surgery, University of British Columbia & British Columbia Children's Hospital, 4480 Oak St., Room K3-159, V6H 3V4, Vancouver, BC, Canada.
Alexander R HengelDivision of Pediatric Neurosurgery, Department of Surgery, University of British Columbia & British Columbia Children's Hospital, 4480 Oak St., Room K3-159, V6H 3V4, Vancouver, BC, Canada.
Aleksander M VitaliDivision of Neurosurgery, Royal University Hospital, Saskatoon, SK, Canada.
Ken PoskittDepartment of Radiology, University of British Columbia & British Columbia Children's Hospital, Vancouver, BC, Canada.
Cynthia HawkinsDivision of Pathology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
James DrakeDivision of Pediatric Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Maria Lamberti-PasculliDivision of Pediatric Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Olufemi AjaniDivision of Neurosurgery, McMaster Children's Hospital, Hamilton, ON, Canada.
Walter HaderDivision of Neurosurgery, Alberta Children's Hospital, Calgary, AB, Canada.
Vivek MehtaDivision of Neurosurgery, Stollery Children's Hospital, Edmonton, AB, Canada.
P Daniel McNeelyDivision of Neurosurgery, IWK Health Centre, Halifax, NS, Canada.
Patrick J McDonaldSection of Neurosurgery, Winnipeg's Children's Hospital, Winnipeg, MB, Canada.
Adrianna RangerDivision of Neurosurgery, Children's Hospital, London Health Sciences Center, London, ON, Canada.
Michael VassilyadiDivision of Neurosurgery, University of Ottawa & Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Jeff AtkinsonDivision of Paediatric Neurosurgery, McGill University Health Centre, Montreal, QC, Canada.
Scott RyallThe Arthur and Sonia Labatt Brain Tumour Research Centre, the Hospital for Sick Children, Toronto, ON, Canada.
David D EisenstatDivision of Hematology, Oncology and Palliative Care, Department of Pediatrics, University of Alberta & Stollery Children's Hospital, Edmonton, AB, Canada.
Juliette HukinDivision of Neurology and Oncology, Department of Pediatrics, University of British Columbia & British Columbia Children's Hospital, Vancouver, BC, Canada.
BC Children's Hospital · CAUniversity of Toronto · CAAlberta Children's Hospital · CAChildren's Hospital of Winnipeg · CAIzaak Walton Killam Health Centre · CALondon Health Sciences Centre · CAMcGill University Health Centre · CAMcMaster Children's Hospital · CARoyal University Hospital · CASickKids Foundation · CAStollery Children's Hospital · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Ottawa · CA

Funding

Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
NHLBI NIH HHS P01 HL092870
6 · The paper itself

Abstract

backgroundThalamic gliomas are rare. The natural history is unpredictable, and the optimal management of these tumors in children is poorly defined. The aim was to identify outcomes, prognostic factors, and response to various modalities of treatment in a relatively large population of pediatric thalamic tumors from many centers within a fairly homogeneous health care system.

methodsWe performed a Canadian multicenter retrospective review of pediatric thalamic tumors presenting during the MRI era (1989-2012). Radiology and pathology were reviewed by central independent reviewers. Paraffin shavings for RNA extraction were taken and tested for fusion events involving KIAA1549:BRAF. Tumors were classified as unilateral or bithalamic based on their origin on imaging. Univariate and multivariate analyses on factors influencing survival were performed.

resultsSeventy-two thalamic tumors were identified from 11 institutions. Females represented 53% of the study population, and the mean age at presentation was 8.9 years. Sixty-two tumors were unilateral and 10 bithalamic. Unilateral tumors had a greater propensity to grow inferiorly towards the brainstem. These tumors were predominantly low grade in comparison to bithalamic tumors which were high-grade astrocytomas. The 5-year overall survival was 61 ± 13% for unithalamic tumors compared to 37 ± 32% for bithalamic tumors (p = 0.097). Multivariate analysis indicated tumor grade as the only significant prognostic factor for unithalamic tumors. Six unilateral tumors, all low grade, were BRAF fusion positive.

conclusionUnilateral and bilateral thalamic tumors behave differently. Surgical resection is an appropriate treatment option in unilateral tumors, most of which are low grade, but outcome is not related to extent of resection (EOR). Bilateral thalamic tumors have a poorer prognosis, but the occasional patient does remarkably well. The efficacy of chemotherapy and radiotherapy has not been clearly demonstrated. Novel therapeutic approaches are required to improve the prognosis for malignant unilateral thalamic tumors and bilateral thalamic tumors.

Indexed as

ThalamusAdolescentAstrocytomaBrain NeoplasmsCanadaChemotherapy, AdjuvantChildChild, PreschoolEpendymomaFemaleGliomaHumansInfantKaplan-Meier EstimateLinear ModelsMagnetic Resonance ImagingBRAF-KIAA1549 fusion protein, humanOncogene Proteins, FusionBrain tumorChemotherapyGliomaOutcomePediatricRadiotherapySurgeryThalamic tumorThalamus

Identifiers

PMID26597682
OpenAlexW2174524951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.